Greyson International

Greyson International is a research and development pharmaceutical company that uses its patented technology Trilexon® to develop enhanced, patent-protected dermatology and healthcare products, including various other medical products. The main goal of Greyson International is to license these prescription and over-the-counter products to the $65 billion global dermatology market and other healthcare markets. Potential licensees include international and multinational pharmaceutical, cosmetic, skincare, and consumer goods companies seeking new products, product improvements, or lifecycle management of existing products.